ARCHIVES

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

DCBDC Board Ok’s New Initiative For Training

November 16, 1990

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011